SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MCorbley who wrote (376)8/15/1997 12:21:00 PM
From: luis a. garcia   of 1115
 
On the other hand Michael there is a 96.5% chance the results are valid in such a large study and that large study and all the others are telling you the same thing lidakol is effective. Even the lidakol placebo supposedly inactive had enuff punch to cure the patients... remember.
The real proof will be how well it will sell over time once it becomes comercialized. Don't forget phase II Kaposi was very good and they are going into phase III this year. I mean this lidakol works...

OBTW is anybody considering selling??

The secondary endpoint reinforces the primary end point and that went off at 99.73% probability that lidakol reduces time to complete healing??? what does that not tell you the story???

luis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext